Should Initial Surveillance of Vestibular Schwannoma Be Abandoned?

ABSTRACT

Early diagnosis of vestibular schwannoma (VS) has increased in recent years because of increased longevity and availability of magnetic resonance imaging (MRI). Initial conservative radiological surveillance is often requested by patients and physicians to establish whether these tumors are growing before embarking on intervention. Initial observation of at least 1 year in all small VS was therefore recommended by some authors. We evaluated our prospective skull base database of VSs that were managed with initial radiological surveillance to establish when this policy should be abandoned and what predicts future growth. Fifty-four consecutive patients with VS in our institution who were managed by initial yearly MRI scanning were studied. The MRI data were collected prospectively and analyzed by Kodak CareStream viewing software where VS maximum diameters in three perpendicular planes and volume were calculated. One patient was excluded from the analysis as he had only one MRI follow-up. The median age of the 53 patients was 59 years (range, 26 to 86 years), 25 were males and 28 were females, and 33 were under 65 years of age; 18 VSs were extracanalicular, 18 were intracanalicular, and 17 extended both inside and outside the canal; 21 VSs were 1.2 cm³ or less, 22 were 1.2 to 4 cm³, and the rest were >4 cm³. Using volumetric analysis, 29.72% of conservatively managed VS grew by at least 2 mm per year, and 70.82% did not grow in 5 years. Age, gender, symptoms, and side did not predict future growth. However, growth in the first year was a strong predictor of future growth (p < 0.001) and initial volume was also a strong predictor of future growth (p < 0.05). Twenty-nine percent of observed VSs grew by at least 2 mm per year in the first 5 years of surveillance. As the growth rate is slow, initial radiological surveillance is justified in elderly patients and patients with small VSs and nonserviceable hearing. Growth in the first year was a strong predictor of future growth. The reported treatment effect should be interpreted in the light of 70.24% of VSs that either shrink or do not change in the first 5 years.

MRI - microsurgery - radiosurgery - schwannoma - vestibular

REFERENCES

• 1 Selesnick S H, Jackler R K, Pitts L W. The changing clinical presentation of acoustic tumors in the MRI era.  Laryngoscope. 1993;  103 (4 Pt 1) 431-436
• 2 Moffat D A, Hardy D G, Baguley D M. Strategy and benefits of acoustic neuroma searching.  J Laryngol Otol. 1989;  103 51-59
• 3 Tos M, Charabi S, Thomsen J. Incidence of vestibular schwannomas.  Laryngoscope. 1999;  109 736-740
• 4 O'Reilly B, Murray C D, Hadley D M. The conservative management of acoustic neuroma: a review of forty-four patients with magnetic resonance imaging.  Clin Otolaryngol Allied Sci. 2000;  25 93-97
• 5 Smouha E E, Yoo M, Mohr K, Davis R P. Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm.  Laryngoscope. 2005;  115 450-454
• 6 Nedzelski J M, Schessel D A, Pfleiderer A, Kassel E E, Rowed D W. Conservative management of acoustic neuromas.  Otolaryngol Clin North Am. 1992;  25 691-705
• 7 Pollock B E, Driscoll C L, Foote R L et al.. Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery.  Neurosurgery. 2006;  59 77-85 discussion 77-85
• 8 Myrseth E, Møller P, Pedersen P H, Lund-Johansen M. Vestibular schwannoma: surgery or gamma knife radiosurgery? A prospective, nonrandomized study.  Neurosurgery. 2009;  64 654-661 discussion 661-663
• 9 Selesnick S H, Johnson G. Radiologic surveillance of acoustic neuromas.  Am J Otol. 1998;  19 846-849
• 10 Flint D, Fagan P, Panarese A. Conservative management of sporadic unilateral acoustic neuromas.  J Laryngol Otol. 2005;  119 424-428
• 11 Stangerup S E, Caye-Thomasen P, Tos M, Thomsen J. The natural history of vestibular schwannoma.  Otol Neurotol. 2006;  27 547-552
• 12 Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): hearing function in 1000 tumor resections.  Neurosurgery. 1997;  40 248-260 discussion 260-262
• 13 Nadol Jr J B, Chiong C M, Ojemann R G et al.. Preservation of hearing and facial nerve function in resection of acoustic neuroma.  Laryngoscope. 1992;  102 1153-1158
• 14 McKenna M J, Halpin C, Ojemann R G et al.. Long-term hearing results in patients after surgical removal of acoustic tumors with hearing preservation.  Am J Otol. 1992;  13 134-136
• 15 Ojemann R G. Management of acoustic neuroma (vestibular schwannoma).  Clin Neurosurg. 1993;  40 498-533
• 16 Glasscock III M E, Hays J W, Minor L B, Haynes D S, Carrasco V N. Preservation of hearing in surgery for acoustic neuromas.  J Neurosurg. 1993;  78 864-870
• 17 Thomassin J M, Epron J P, Régis J et al.. Preservation of hearing in acoustic neuromas treated by gamma knife surgery.  Stereotact Funct Neurosurg. 1998;  70 (S 01) 74-79
• 18 Yang I, Sughrue M E, Han S J et al.. A comprehensive analysis of hearing preservation after radiosurgery for vestibular schwannoma.  J Neurosurg. 2010;  112 26-32